Artificial eye is also referred as visual prosthetic. It is the artificial visual device used to restore the visual function of the patient suffering from complete or partial blindness. Number of devices are available in the market which can cure or improve the eyesight of the patient. Global artificial eye market is driven by increasing number of people suffering from complete or partial blindness. According to WHO, approximately 250 million people of 50 years age are suffering from visual impairment. Around 80% people in many of the developing countries are suffering from eye sight problems of which nearly 50% of people are not able to take treatment due to its high cost. Global artificial eye market is driven by increasing number of people suffering from complete or partial blindness and increasing aging population. Increasing prevalence of diseases affecting eye sight, developments in technology and increasing prevalence of diseases like diabetes is also contributed in the growth of the market. While high cost of the treatment and availability of cheap alternative treatment has hampered the growth of the market. Global artificial eye market size is growing at a CAGR of 9.6% during forecasted period 2017-2023.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/985 Key players for global artificial eye market Advanced Artificial Eye (US), The National Artificial Eye Services (NHS) (UK), Marie Allen Ocularist Ltd (Canada), COS-MEDIC PTY LTD (Australia), Retina Implant AG (Germany), Second Sight (US), Pixium Vision (France), Ericksons Custom Made Artificial Eye (Canada), International Prosthetic Eye Center (India) Segmentation Global artificial eye market is segmented on the basis of type, Non-integrated implants, Integrated implants. Integrated implants are further segmented into hydroxyapatite, porous polyethylene, bioceramic, conical orbital implant and other. On the basis of technology, they are segmented into electronic and mechanical and on the basis of end user, the market is segmented into hospitals, ophthalmology clinics and others. Regional analysis On regional basis, America dominates the global artificial eye market. Development in technology and increasing people suffering from eye sight problem due to increasing prevalence of diabetes has driven the growth of the market. Europe commands the second largest market for the artificial eye which is followed by Asia Pacific. The report for global artificial eye market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. Intended Audience
About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected]
0 Comments
The global healthcare supply chain management market is expected to grow significantly over the forecast period. It is estimated that the global healthcare supply chain management market size is expected to register a CAGR ~ 8.2 % during the forecast period from 2018 to 2023. Supply-chain management is a process which includes planning, design, execution, control, and monitoring flow of various goods and services to create competitive logistics infrastructure, increases net value, synchronizing demand and supply of goods to measure performance. The major driving factors of supply chain management in healthcare are increasing globalization, expanding business, fast product life cycle, increasing fragmentation in the healthcare industry, the high economy of scale and other. The other factors responsible to support the market are increasing customer demand, rising customization, growing capabilities of technology and other. However, factors like lack of awareness, low innovation, the high cost of maintenance and installation, issues of integration may restrain the growth of the market.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5716 Healthcare Supply Chain Management Market Segmentation The Healthcare supply chain management market has been segmented into models, functions, delivery mode, software, technology, and end users. The market, on the basis of models, has been segmented into, build-to-order, make-to-stock model, continuous replenishment model, chain assembly and others. On the basis of function, Healthcare supply chain management market is sub-segmented into forecasting and planning, warehousing and distribution, inventory management and procurement, internal logistics and operations, reverse and extended logistics and others. On the basis of delivery mode, Healthcare supply chain management market further segmented into on-premise, web-based, and others. On the basis of software, Healthcare supply chain management market is sub-segmented into planning tools and execution tools. The planning tools are sub-segmented into forecasting and inventory management, supplier and vendor management, production and sales planning, others. Execution tools are further sub-segmented into warehouse management, order processing and status tracking, others. On the basis of technology, the market is sub-segmented into a barcode, radio frequency identification (RFID), global positioning system (GPS), internet of things and big data, others. On the basis of end users pharmaceutical and biotech companies, logistics companies and distributors, healthcare providers, and others. Healthcare supply chain management market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Healthcare supply chain management market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European healthcare supply chain management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The healthcare supply chain management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Healthcare supply chain management market in the Middle East & Africa has been segmented into the Middle East and Africa. Healthcare Supply Chain Management Market Key players The major key players of the global healthcare supply chain management market include SAP (Germany), Infor (US), Oracle (US), GHX (US), TECSYS (Canada), McKesson (US), Manhattan Associates (US), Jump Technologies (US), JDA Software (US), and LogiTag Systems (Israel), Advocate Health Care (Murray, UT), and others. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-supply-chain-management-market-5716 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Market – Global Overview
The worldwide pulse oximeters industry is predicted to grow at around 6.5 percent during the forecast period (2017 to 2023). Pulse oximeters are used to assess key medical parameters; like cardiac, pulse, and breathing rates. They are employed to analyze the health of patients during the detection of their illnesses or when they display symptoms. These products are adopted across homes, healthcare settings, healthcare emergencies. Rising elderly populace, preference for home surveillance, and chronic illnesses are some of the factors that drive this industry. Apart from these, heart problems and obesity coupled with unhealthy living conditions can also contribute market sales in the near future. Browse Sample of the Report @ @ https://www.marketresearchfuture.com/sample_request/5671 Bad eating choices and consumption of junk food are the probable factors, reported to cause heart ailments, hypertension, and diabetes. Both these factors augur well for the industry and propel its revenues. In addition to the above factors, consumer awareness regarding ‘state-of-the-art’ pulse oximeters is said to boost market growth. On the other hand, the key factor which hinders the industry is the shortage of awareness about these devices across middle & low income families. Considering the overall scenario, the pulse oximeters market is set to attain remarkable growth from 2017 to 2023. This fact is credited to the wider presence of cardiac arrhythmias, ischemic ailments, sleep apnea, and some others. Innovations in technologies have resulted in customer-friendly and enhanced devices, resulting in higher market demand. For example, back in 2015, a wireless fingertip oximeter was introduced that could operate through Bluetooth. The said device possesses low power and was directed at recognizing untimely-involvement patients suffering from COPD and other breathing disorders. Scarcity of well-established reimbursement regulations and heavy medical expenses urge patients to select home care and the convenience that comes along with it. This factor raises the need for remote patient surveillance devices, again leading to the growth of pulse oximeters. Quick sanctions on novel products & services also go a long way in promoting this market. The global industry is experiencing constant mergers and acquisitions coupled with its other expansion strategies. Such an instance is the acquirement of a ‘Vital Signs’ company unit in 2013 by ‘CareFusion Corp.’ The deal was too good & reported to generate more incomes for specialized disposable businesses. The market is fragmented on the basis of products, applications, and regions. Segments – Detailed Outlook The pulse oximeters industry, in terms of products, consists of handheld, fingertip, and others. The various application sub-segments are medical amenities, hospitals, respiratory & cardiac centers, homecare, etc. Regions into which the market is split, comprise Asia Pacific, Europe, Americas, and the Middle East and Africa. Among products, handheld devices led the market. The shares of handheld pulse oximeters were ascribed to massive ‘vital stats’ device usage and escalating surgical procedures. Additionally, the early diagnosis of life-long illnesses & disorders lowers more complexities and assists better treatments. Moreover, the identification of health risks are always beneficial in preventing other illnesses or relapses. Also, heightened awareness about the significance of keeping patients under proper observation has positively impacted the market. Fingertip devices have also become more popular, with them being the most rapidly evolving sub-segment. Their non-invasive nature has helped them gain traction & patient convenience. With respect to applications, medical amenities and hospitals maintained supremacy over the industry. The said fact was basically credited to multiple hypertension, heart arrhythmia, and COPD incidences. The global market was led by Americas. Europe was close behind, followed by Asia Pacific that was likely to be the fastest expanding market over the forecast period. Competition, Players’ Strategies, and Recent News The worldwide pulse oximeters market is fairly competitive, with various companies developing new products & services to remain ahead of one another. Product sanctions and mergers & acquisitions are some of the common strategies used by these players. Recently, a new oximeter, ‘Elera Starhealth’ was launched to make reading simple for the patients. It can operate non-stop for fifty hours & provide rapid & precise spot checks, as and when needed. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pulse-oximeters-market-5671 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Market Overview
Global Surgical Instrument Tracking System Market was valued at USD 186.85 Million in 2019 and is expected to register a CAGR of 15.07% during the forecast period of 2020 to 2027. Surgical instrument tracking systems are systems that can combine scanning technology and application software. They help healthcare professionals to access time-saving tools, leading to them performing efficient and time-saving procedures. The surgical tracking systems are very much useful in organizing surgical sets, usage cycle tracking, and documentation of instruments used, understanding the replacement of instruments, and other applications. Factors that drive the market growth are the high rate of adoption of the surgical instrument tracking systems by hospitals, the need to meet unique device identification mandates, the convenience provided by surgical instrument tracking system in the management of inventories, and the increasing number of surgical instruments used in various surgeries. However, the high cost of implementing automated tracking systems coupled with a fall in the number of surgeries due to a pandemic is hampering the growth of the market. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1391 Previously, it was only used for instrument count sheet management along with a few basic tasks such as traceability of instruments. The 2D barcodes have helped sterile handling and identification of instruments and help in tracking the history of each instrument’s use. Major healthcare providers are signing long-term agreements with surgical instrument tracking system suppliers for improving the quality of the inventory management systems. For instance, recently, Universal Health Services, Inc., one of the hospital management companies, which have a large network of hospitals in the US, signed a multi-year contract with Censis Technologies, Inc. for its surgical instrument tracking system Censitrac. Market Dynamics The surgical instrument tracking systems are used in the healthcare facilities to streamline the workflow, regulate the costs, and reduce waste as well as for effective inventory management. There are several benefits of surgical instrument tracking systems. Key players operating in the surgical instrument tracking system market are engaged in the acquisition of companies with similar products to expand their product portfolio and maintain a global footprint. For instance, in October 2019, Fortive Corporation (US) acquired Censis Technologies, Inc. (US). This acquisition helped Fortive Corporation to add a surgical instrument tracking systems product portfolio. The growth of the global surgical instrument tracking system market can be attributed to the high rate of adoption of the surgical instrument tracking systems by hospitals, technological advancements in the surgical instrument tracking system market, and the growing number of surgical procedures globally. Technological advancements in the surgical instrument tracking system segment are reducing the time required for the process and increasing the accessibility and efficiency of inventory management in the medical facilities. It is also providing real-time data collection and monitoring of surgical instruments used in the healthcare facility. The market players have been engaged in the development of innovative products and services for catering to the needs of the healthcare providers. For instance, in October 2018, Spa Track launched a new Auto-Scanner RFID Surgical Instrument. It is a hetero-directional, rotating processing system that takes only 12 seconds for screening a complete instrument plate and can be inaccurate monitoring of every single registration number of items. Such technological advancements are expected to encourage the growth of the global surgical instrument tracking system market during the forecast period Segmentation Global Surgical Instrument Tracking System Market has been divided based on Components, Technology, and End-Use. The market, based on components, has been segmented into hardware, software, and services. The hardware segment accounted for a significant market share of 51.6% in 2019. This large share can be attributed to its growing technological advancements, which is driving the adoption of these devices for inventory management. The hardware segment is further divided into readers, tags, and others. The market, based on technology, has been bifurcated into barcode tracking and radio frequency identification. The Barcode tracking segment dominated the global surgical instrument tracking system market in 2019. Owing to the low cost of installation has resulted in the increased adoption of barcode technology in the surgical instrument tracking systems market. It held a market share of 86.9% in 2019. On the basis of end use, the global surgical instrument tracking system market has been classified as hospitals and others. The hospitals segment dominated the global surgical instrument tracking system market in 2019. The large share of 83.0% of hospitals is attributable to the need to cut healthcare expenditure and manage existing instruments for tracking solutions. Regional Analysis Global Surgical Instrument Tracking System Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global surgical instrument tracking system market owing to the awareness about inventory management and better care for patients, need to cut healthcare costs, highly developed healthcare infrastructure, and availability of advanced products. In 2019, the Americas accounted for a considerable market share of 45.9% in the global surgical instrument tracking system market. Other factors attributed to this larger market share are government regulations and rising healthcare expenditure by the countries in the region. Europe held a substantial share in the global surgical instrument tracking system market. The surgical instrument tracking system market in Europe is expected to propel during the forecast period, owing to factors such as growing demand for surgical treatment, improving economies, high disposable income per individual, and increased healthcare spending. In addition, the presence of highly developed healthcare infrastructure and the rapid adoption of advanced technology and products are expected to have a positive impact on the European surgical instrument tracking system market The fast growth of the Asia-Pacific region is due to the rising geriatric population, increasing number of patients suffering from oncological problems, and the increasing per capita income along with increasing availability of products from leading players. For example, Getinge AB caters its products and services to Japan, East Asia, and South Asia Pacific. The market in the Middle East & Africa with less economic developments and extremely low income accounted for the least market share in 2019 but is expected to grow with the increasing number of surgical procedures coupled with rapidly developing healthcare infrastructure. Additionally, the Department of Culture and Tourism – Abu Dhabi (DCT) recently signed a memorandum of understanding with the Medical Tourism Association (MTA), a non-profit organization that aids healthcare providers and governments create successful medical tourism programs. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-instrument-tracking-system-market-1391 Market Scenario:
A surgical chip is a recognizing coordinated circuit gadget / RFID transponder encased in silicate glass and embedded in the body of a person. A sub dermal implant ordinarily contains an exceptional ID number that can be connected to data contained in an outside database, for example, individual recognizable proof, medicinal history, meds, allergies, and contact information. The global Surgical Chips Market is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX% Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1310 Key Players for Surgical Chips Market: Some of the key players in this market are: Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer, Inc. (US) Fluidigm Corporation (US) Illumina, Inc. (US) GE Healthcare (UK) Bio-Rad Laboratories Inc. (US) Cepheid (US), Thermo Fisher Scientific, Inc. (US) Roche Diagnostics (Switzerland) Segments: Global Surgical Chips market has been segmented on the basis of types which comprises of DNA Chips, brain chips, lab chips, protein chips, tissue chip and others. On the basis of end users which consists of hospitals, clinics, research facilities and others. On the basis of application which consists of Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics and others Regional Analysis of Surgical Chips Market: Globally North America is the largest market for Surgical Chips. The North American market for Surgical Chips is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. This is due to increasing healthcare R&D expenditure and improvement of healthcare technology. Europe is the second-largest market for Surgical Chips which is expected to grow at a CAGR of XX%. Whereas Asia pacific is expected to be a growing market for Surgical Chips market The report for Global Surgical Chips Global Surgical Chips market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-chips-market-1310 Market OverviewAccording to MRFR, the global throat lozenges market is expected to witness a moderate CAGR of 4.20% and generate a market value of USD 6.58 Billion by the end of 2023.
COVID-19 AnalysisA positive effect of the COVID-19 pandemic is expected on the Global Throat Lozenges Market. The typical signs of COVID-19 are a sore throat and coughing. Therefore, people under home confinement have been using at-home remedies for COVID-19 such as throat lozenges for chronic cough and over-the-counter pain relief for body aches. Therefore, in the next 2 to 3 years, the growing demand for throat lozenges for the treatment of initial COVID-19 symptoms of coughing and throat pain is expected to fuel the growth of the market for throat lozenges. The growing demand for throat lozenges has also led to the production of throat lozenges by companies from different industries. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1212 Growing Prevalance of Sore Throat Causing Disorders to Drive Market Growth Throat lozenges are sold in bulk and are low-cost for the treatment of sore throat caused by respiratory illnesses or common cold, similar to most medical options. Similarly, the growth of the demand for throat lozenges is also driven by a growing number of HIV patients around the world, since HIV patients typically suffer from throat infection. Furthermore, evolving habits will further stimulate the development of the demand for throat lozenges, as modern lifestyles are responsible for reducing the body's immunity. These are sold in various varieties and are Over-the-Counter (OTC) products, making them easy for patients to use. Often, at the time of buying, throat lozenges do not require any prescriptions, resulting in quick commercialization of the medication. Due to an improvement in at-home care of sore throat and cough, the ease of distribution of these items stimulates consumer moving. Throat lozenges brands continue to exploit marketing tools to improve the commercial exposure of their label. The production of new products, rapid product penetration in fast-developing markets, and low prices of throat lozenges are other factors correlated with the growth of the global demand for throat lozenges. Opportunities Product Innovation to Create Growth Avenues for Key Players Innovative product offerings which are expected to yield business prospects in the coming years are gradually being launched by market players. Brands are adding new flavours, which have a positive impact on the market, to give buyers more options. Restraints Access to Alternative OTC medication to Impede Market Growth The availability of alternative over-the-counter medication methods for throat infections has led to developments in medicine and continuing study & development of alternative as well as more efficient treatments. Non-steroidal anti-inflammatory medications (NSAIDs) are useful for pain management and inflammation control, often related to a sore throat or throat infection. The development of the throat lozenges market is threatened by other substitutes such as throat sprays, cough syrups and antiseptic gargling solutions. Segmental AnalysisBy Type More than 45 percent of the market comprises hard candy lozenges that come in a range of shapes, sizes, and tastes that make them particularly popular with people of ages. Compressed lozenges are the fastest-growing segment that will evolve during the appraisal period at a CAGR of 4.35 percent. Long-lasting compressed lozenges and an extended breakdown period offer long-lasting relief. By Ingredient Menthol accounts for the most relevant ingredient category and is estimated to be worth USD 2084.62 Mn by the end of the appraisal period. Although the compound itself has few medicinal advantages, the taste is incredibly common, placing it in a position of leadership. With the highest estimated CAGR of 4.72 percent during the forecast period, eucalyptus oil accounts for the fastest rising category. Eucalyptus oil is a historically used antibacterial component attributed to long-lasting soothing properties, making it increasingly popular. By Indication With respect to market share, the sore throat segment is well ahead of all other categories. Meanwhile, the cough & cold segment, which is predicted to undergo the highest CAGR of 4.51%, is the fastest rising segment. Combined with elevated cases of common cold, the infectious aspect of cough & cold is expected to fuel development in the market. Regional AnalysisPresence of Major Players Drives North America North America and South America are broadly split between the Americas, with a share of over 70 percent in the North American market. Due to the emergence of an increasingly growing ageing demographic, the Americas is the main regional consumer segment. Moreover, rising government spending and the presence of a wide range of product options push the market. One of the most significant markets at the national level is the U.S. The American economy is projected to expand at a CAGR of 3.27 percent during the estimation period. Germany to Drive Europe Market Growth In terms of market size, Europe leads the Americas and follows a similar pattern of growth. As main factors for the sector, growing government spending and a rising birth rate have been established. The development of Europe's demand for throat lozenges is motivated by the emergence in the area of a significant number of suppliers of throat lozenges, along with growing government spending and the availability of a wide range of product offerings. In addition, cool temperatures in countries accentuate the occurrence of cold and cough, which in turn fuels demand in the demand for European throat lozenges. Rising Awareness of OTC Medicines to Drive APAC Meanwhile, it is anticipated that the Asia Pacific market will be the fastest growing market, with a CAGR of 4.77 percent during the projected period. Emerging economies such as China, Japan, and India are among the markets in the region. Main drivers of the APAC industry have been found to be fast economic development, awareness of over-the-counter medicine and its cost-effectiveness. The area has a large paediatric population and an increasing geriatric population that also leads to the development of regional markets. Competitive LandscapeMergers and Acuisitions to Remain Primary Focus of Market Players There are several competitors competing in the global market for throat lozenges. Global throat lozenges market is heavily saturated due to the involvement of a large number of local and multinational corporations. A vast variety of items on the market are available. The majority of businesses concentrate on cost-effective drugs, while others have embraced merger tactics and strategic partnerships for commercial expansion. Any of the major companies, taking advantage of their good position and presence in the number of countries and regions around the world, have gained a large share of the global market. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-lozenges-market-1212 Market Scenario
The global digital genome market is expected to witness tremendous growth during the forecast period. Digital genome can be used in the diagnosis of rare diseases, genetic diseases, cancer, neurological disorders and others. The rising prevalence of chronic diseases such as breast cancer is driving the market growth. Other essential factors influencing the growth of the market are increasing geriatric population, need for efficient diagnosis and treatment, increasing number of drug discoveries, growing biotech sector, increasing research in the field of genomics and rise in funding related to digitalization. Variants of Presenilin gene lead to Alzheimer’s disease. According to Alzheimer's Association in 2018, 5.7 million people are from Alzheimer’s disease in the Americas. With the help of digital genome identifying genomic variants is easy. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1125 However, factors such as high costs of digital genome techniques, lack of knowledge about the digital genome, security issues and inaccurate results are some of the factors expected to hinder the market growth during the forecast period. Global Digital Genome Market, by Key Players
The global digital genome market is segmented on the basis of product, application, and end-user. The global digital genome market, by product, is segmented into sequencing services, sequencing instruments, sequencing consumables, bioinformatics and sample preparation kits and reagents. The application segment is segmented into diagnostics, agriculture & animal research, personalized medicine, drug discovery and treatment analysis. On the basis of end-user, the market is categorized into research centers and government institutes, academic institutions, pharmaceutical & biotechnology industries, hospitals, and diagnostic centers. On the basis of region, the global digital genome market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa. Regional Market Summary The digital genome market is dominated by America owing increasing prevalence of chronic diseases like cancer and diabetes. The Breastcancer.org estimated 266,120 new cases of invasive breast cancer and 63,960 new cases of non-invasive breast cancer in America in 2018. Thus, this provides favorable backgrounds for the market to grow. It is estimated that Europe stood second in the global digital genome market. The rising demand for personalized medicine and targeted therapy is driving the growth of the market. The European Alliance for Personalized Medicine (EAPM) founded in March 2012, is involved in enhancing patient care for chronic diseases through personalized medicine. According to the European Commission in April 2018, 13 European countries have signed a declaration to share the genomic data to allow personalized treatments against cancer, rare diseases, and neurological diseases. The digital genome market in Asia-Pacific is expected to witness growth owing to rising diabetes in this region. According to the American Diabetes Association in 2016, the Western Pacific has more than 138.2 million diabetic patients. Also, the rising healthcare spending and growing biotech sector drive the market growth in this region. The Middle East and Africa holds the least share in the global digital genome market due to low funding in medical and health research. However, the rising prevalence of chronic diseases and increasing healthcare spending favors market growth in this region. According to the Ministry of Finance - KSA (Kingdom of Saudi Arabia) in 2018, 147 billion riyals (USD 39.2 billion) have been allocated for the Health and Social Development Sector. This enhances the market growth of digital genome in this region. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-genome-market-1125 The Global Non-Invasive Monitoring Device Market is expected to register a CAGR of 6.80% and is anticipated to reach USD 21,586.2 Million by 2023. Monitoring the patient condition is one of the significant parts of any treatment process for any disease condition. Monitoring devices are playing a vital role in providing the best possible care to the patients. There are three types of monitoring devices; invasive, minimally invasive, and non-invasive monitoring devices. Non-invasive devices are in high demand from the healthcare providers as well as patients due to their advantages over invasive monitoring. Non-invasive monitors are very much different from invasive monitors in terms of their working principle. Non-invasive monitors do not require rupturing of skin and penetration of any device into the body of the patient. Non-invasive monitors have sensors attached which play an essential role in generating readings of the body vitals.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1506 The increasing prevalence of cardiovascular diseases, increasing adoption of non-invasive technology, increasing prevalence of neurovascular diseases, increasing geriatric population, and favorable reimbursement policies are the major drivers propelling market growth. However, the erroneous readings and stringent regulatory norms constrain the growth of the market. Market Dynamics According to a report published in 2015 by the Center for Disease Control and Prevention (CDC), every year, more than 630,000 Americans die from heart diseases. Moreover, according to a report published by the CDC, in 2017, nearly 30.3 million people have diabetes only in the US. That means, one person out of every ten people has diabetes. Increasing prevalence of cardiovascular diseases has created a unique demand for advanced non-invasive monitoring devices. Additionally, increasing risks and patients suffering from diabetes & obesity, developing technology, and growing demand for monitoring devices will fuel the growth of the market during the forecast period. Segmentation The global non-invasive monitoring device market has been segmented into type, modality, application, and end user. By type, the market has been segmented into cardiac monitoring devices (electrocardiography and cardiac output monitors), brain monitoring devices, blood pressure monitoring devices, anesthesia monitoring devices, and blood glucose monitoring devices. Based on modality, the market has been segregated into table-top devices and wearable devices. By application, the market has been divided into cardiology, neurology, and oncology. On the basis of end-user, the market has been classified as hospital & clinics, diagnostic centers, and research & academic institutes. The hospitals and clinics segment accounted for a market value of USD 5457.4 million in 2016. Key Players The prominent players in the global non-invasive monitoring device market are General Electric Company (US), Medtronic PLC (Ireland), KONINKLIJKE PHILIPS NV (Netherlands), Abbott (US), Omron Corporation (Japan), Vaso Corporation (US), Integrity Applications (Israel), CAS Medical Systems, Inc. (US), A&D Medical Inc. (Japan), Tensys Medical Inc (US), OrSense Ltd (Israel), CNSystems Medizintechnik AG (Austria), NIMedical (Israel) and Advanced Brain Monitoring, Inc (US). Some of the key strategies followed by the players operating in the global non-invasive monitoring device market were innovation, product development, acquisition, and expansion. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] |
MRFRWe Provide Deep Market research Reports Categories |